胆酸代谢在学习和记忆障碍中发生变化,这是由慢性暴露引起的
Anfei Liu1, Yunting Li1, Lifan Li1
1Department of Occupational Health and Occupational Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515, China.
Journal of hazardous materials
|April 25, 2024
概括
慢性低剂量暴露会通过破坏肠道微生物群和胆酸代谢,损害学习和记忆. 特定的胆酸补充可能为诱导的神经毒性提供治疗策略.
科学领域:
- 环境健康 环境健康
- 神经科学是一个神经科学.
- 微生物学 微生物学
背景情况:
- 是一种广泛存在的环境神经毒剂.
- 的神经毒性与肠道微生物群的干扰有关,但其对宿主代谢障碍的影响尚不清楚.
研究的目的:
- 研究肠道微生物群介导的宿主代谢障碍在诱导的神经毒性的作用.
- 探索针对胆酸代谢的潜在治疗策略.
主要方法:
- 在老鼠中慢性低剂量暴露.
- 行为测试 (新的物体识别,莫里斯水迷宫).
- 16S rRNA测序,便微生物种移植,非向代谢和胆酸向分析.
主要成果:
- 暴露导致学习和记忆缺陷.
- 的神经毒性通过肠道微生物群传播.
- 暴露改变了血清胆酸概况.
- 甲酸 (TUDCA) 和INT-777补充剂通过抑制海马NLRP3炎症酶和神经炎症来改善认知缺陷.
结论:
- 失调的胆汁酸代谢与诱导的神经毒性有关.
- 用特定胆汁酸补充显示了对神经毒性的治疗潜力.
相关概念视频
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Role of Neurotransmitters in Memory
535
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
535
Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
121
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
121


